---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "CDN STBBI Guidelines"
developer_entity: "Health Canada / Santé Canada"
bundle_id: "ca.gc.hcsc.sti"
app_store_id: "958263397"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-03-27"
report_date: "2026-09-09"
last_verified: "2026-09-09T00:00:00.000Z"
report_version: "3.7.3"
total_reviews: 0
sentiment: "Mixed"
sentiment_score: 50
confidence: "medium"
confidence_score: 0.55
top_praise_theme: "Users value the simple access to information provided within the application for their daily needs"
top_complaint_theme: "The search function performs poorly and fails to link to content after the latest update"
review_sample_size: 4
total_review_count: 4
analyzed_review_count: 4
data_age_days: 29
momentum_velocity: "maintenance"
intelligence_version: 3
tags: ["medical", "free", "mixed sentiment", "mobile app", "app review", "app analysis", "canadian", "health", "professionals,"]
canonical_url: "https://marlvel.ai/apps/cdn-stbbi-guidelines"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# CDN STBBI Guidelines Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Sentiment Mixed
- **Recent focus**: The search function performs poorly and fails to link to content after the latest update (top complaint) · Users value the simple access to information provided within the application for their daily needs (top praise)

> **TL;DR:** CDN STBBI Guidelines is a medical app by Health Canada / Santé Canada, with Mixed user sentiment (50/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** CDN STBBI Guidelines is a medical app by Health Canada / Santé Canada.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **User Mood** | Mixed |
| **Category** | Medical |
| **Developer** | Health Canada / Santé Canada |
| **Pricing** | Free |
| **Platforms** | iOS & Android |
| **Confidence** | Medium (0.55/1.0) |
| **Data Age** | 29d |

## Metadata & Market Performance
- **Publisher:** Health Canada / Santé Canada
- **Category:** Medical
- **Target Audience:** Canadian health professionals, including public health and clinical practitioners.
- **Platforms:** iOS & Android
- **Version Reviewed:** 3.7.3
- **Report Date:** 2026-09-09
- **Signal Count:** 4 reviews analyzed
- **Confidence:** Medium (0.55/1.0)
- **App Store ID (iOS):** 958263397
- **Bundle ID:** ca.gc.hcsc.sti
- **Google Play ID:** ca.gc.hcsc.sti
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-09-09

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** CDN STBBI Guidelines is a clinical reference tool for Canadian health professionals, providing standardized STI screening and management protocols on iOS and Android.
**Why users hire it:** The application removes the cognitive friction of cross-referencing multiple paper-based or web-based clinical guides during patient consultations.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Clinical STI Guidelines:** Standardized screening, diagnosis, and management protocols for STIs.
  * *User Intent:* Users need clear guidance to understand and adopt the product quickly.
- **[Differentiator] Antibiotic-Resistant Gonorrhea Protocols:** Specific clinical guidance for managing resistant gonorrhea strains.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Cross-Resource Integration:** Incorporates HIV and Hepatitis B management recommendations.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

CDN STBBI Guidelines occupies a niche as a government-issued clinical utility, with no direct commercial competitors in the Canadian medical app space.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free
- **Analysis:** The application is a free public health resource provided by the Government of Canada with no monetization or in-app purchases.

<!-- section:sentiment -->
## 🟡 User Sentiment (Medium Confidence: 4 of 4 reviews analyzed) {#user-sentiment}
- **Overall Sentiment:** Mixed

### Top Praises
- **Users value the simple access to information provided within the application for their daily needs**

### Top Complaints (Impact Areas)

- **The search function performs poorly and fails to link to content after the latest update**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Centralized clinical protocol library reduces cognitive load during consultations

**Growth Levers:**
- Integration of visual diagnostic aids addresses primary user request


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The outlook for the application has declined from mixed to declining due to a lack of active development and persistent navigation failures. The app remains in a maintenance-only state, which now explicitly threatens its viability as a clinical reference tool.

**Overall trend**: Declining
**Compared at**: 2026-09-09

### High-impact changes
- **[Declined] Outlook trend downgrade** (positioning)

### Medium-impact changes
- **[Shifted] Government status re-characterized as a liability** (positioning)
- **[Shifted] Threat profile update** (swot)

<!-- section:whats-new -->
## What's New

- **Latest (v3.7.3, 5 months ago):** Introduced a Prevention Guide and enabled support for 16kb pages.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Ships bug fixes at 5-month cadence.
- No new feature updates since 2026.

> **Cadence:** 1 total versions · 1 majors in last 6 months · 165 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

CDN STBBI Guidelines is a medical app that is completely free.

<!-- speakable-start -->
> **Bottom Line:** Restoring search-link reliability would immediately stabilize the core utility for clinical practitioners, as the current navigation failures undermine the app's value as a trusted reference tool.
<!-- speakable-end -->

**Best for:** Canadian health professionals, including public health and clinical practitioners.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Rebuild search-link logic because current navigation failures block clinical utility -> restore core reference value
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Declining

The clinical reference market is shifting toward dynamic, frequently updated digital tools that integrate directly into electronic health records. CDN STBBI Guidelines remains in maintenance mode, leaving it exposed to navigation regressions that directly impact its utility for time-constrained health professionals.

- 🔴 Broken search functionality post-update blocks clinical utility, which erodes practitioner trust in the app as a reliable reference tool.
- 🔴 The five-month gap between updates indicates a maintenance-only cadence, preventing the integration of emerging STI management trends.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Sentiment | Mixed (50/100) |
| Confidence | Medium |
| Pricing Model | Free |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **CDN STBBI Guidelines** (this app) | N/A/5 | Mixed | Health Canada / Santé Canada |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Health Canada / Santé Canada
- **Website:** [https://www.phac-aspc.gc.ca/std-mts/sti-its/index-eng.php](https://www.phac-aspc.gc.ca/std-mts/sti-its/index-eng.php)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/cdn-stbbi-guidelines/id958263397?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=ca.gc.hcsc.sti&hl=en&gl=us)
- **Dev Site:** [Official Website](https://www.phac-aspc.gc.ca/std-mts/sti-its/index-eng.php)
- **Sources:** Developer website content, About us / company information, App store metadata, User reviews.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.55/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 4
- **Data Sources:** user reviews, developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 29 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/cdn-stbbi-guidelines)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.